Skip to content
The Nexus
DossierENTITY

FDA Center for Drug Evaluation and Research

Coverage of FDA Center for Drug Evaluation and Research in the Nexus archive.

Earliest in view: Jun 14 · 17:19 UTCMost recent: Jun 16 · 07:10 UTC
Co-mentioned in this coverage
Recent coverage
  • POLITICSJun 16 · 07:10 UTCOHIO CAPITAL JOURNAL
    Republican attorneys general urge EPA to classify mifepristone as water contaminant

    Fourteen Republican state attorneys general and 19 GOP members of Congress are urging the EPA to classify mifepristone, an abortion medication, as a water contaminant. Environmental experts and the Center for Biological Diversity state there is no evidence of harm from mifepristone in water systems, citing a 1996 FDA statement and common drug trace amounts in water.

  • POLITICSJun 15 · 14:18 UTCARIZONA MIRROR
    Republican attorneys general urge EPA to classify mifepristone as water contaminant

    Fourteen Republican state attorneys general and 19 GOP members of Congress are urging the EPA to classify mifepristone, an abortion medication, as a water contaminant. Environmental experts state there is no evidence that mifepristone in wastewater harms humans or the environment, while the request cites a 1996 FDA statement acknowledging the drug may enter the environment but noting harmful effects are 'not anticipated.'

  • POLITICSJun 14 · 17:19 UTCNC NEWSLINE
    Republican attorneys general urge EPA to classify mifepristone as water contaminant

    Fourteen Republican state attorneys general and 19 GOP members of Congress are urging the EPA to classify the abortion medication mifepristone as a water contaminant, citing a 1996 FDA statement. Environmental experts and the Center for Biological Diversity state there is no evidence mifepristone harms water systems or humans, while state lawmakers in seven states introduced bills addressing medication abortion's environmental impact.